CA
NZ
UK
AU
IND
US
The Oncology Institute, Inc. filed a Current Report on Form 8-K on August 3, 2026, disclosing that the company changed its legal name to Starling Oncology, Inc., effective July 28, 2026, and that its Nasdaq trading symbol changed from TOI to STLN beginning August …
United Community Banks, Inc. filed a Form 8-K with the SEC on August 3, 2026, reporting the closing of its previously announced acquisition of Peach State Bancshares, Inc. and its wholly-owned subsidiary, Peach State Bank & Trust.
United Community Banks, Inc. filed a Form 8-K with the SEC on August 3, 2026, disclosing the appointment of Carl Carande to its Board of Directors effective August 1, 2026.
EchoStar Corporation and its subsidiary Hughes Satellite Systems Corporation filed a current report on Form 8-K dated August 3, 2026, disclosing that HSSC and eleven of its wholly-owned subsidiaries voluntarily filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the …
Avista Corporation (NYSE: AVA) filed a Current Report on Form 8-K on August 3, 2026, disclosing that multiple fires broke out on August 1, 2026, in the Spokane, Washington area within the company's electric and natural gas service territory, causing widespread outages and significant …
Teradata Corporation (NYSE: TDC) filed a Form 8-K on August 3, 2026, disclosing the election of Bernd Leukert as a Class II director to its Board of Directors, effective August 1, 2026, in connection with a previously announced Cooperation Agreement.
American Bitcoin Corp. filed a Form 8-K on August 3, 2026, disclosing the departure of President and Interim Chief Financial Officer Matthew Prusak and the appointment of Paul Sacks as Interim Chief Financial Officer, both effective August 4, 2026.
Supernus Pharmaceuticals, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 3, 2026, disclosing its financial results for the second quarter ended June 30, 2026, and announcing a definitive all-stock merger agreement with Indivior Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) filed a current report on Form 8-K on August 3, 2026, disclosing a joint investor conference call and webcast with Indivior Pharmaceuticals Inc. regarding a proposed merger of the two companies.
1. IRAN: Trump Cancels Planned Strike, Would Have Been Biggest Since WWII; Talks Set to Begin Monday Afternoon; Iran Denies Any Negotiations Planned; Oil Crashes 6%
Please wait processing your request...